TFBS BIOSCIENCE, INC.
Update：2023/06/12
Industries
Main Industry
Biotechnology
Main Product/Service
TFBS provides two main services: One service is the viral vector manufacturing for cell and gene therapy products. With established expertise and effective communication, TFBS has successfully completed several customized viral vector manufacturing projects. Another service is to provide biosafety testing and product release testing for cell and gene therapy products, vaccines and biologic products. Based on over ten years of experience rooted back in the development stage associated with the government research institute, TFBS also acquired expertise to support clients in assay development and optimization for their product development.
Founded Year
2016
Unified Business No.
52209120
Status
Active
Number of Employees
65
Total Paid-in
Capital
349,391,610 (NT$)
Location of Company
Taiwan
, New Taipei City
Exit Status
Emerging Stock Exchange(2023)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Exclusive content for members
Members-only content. Please log in to access.
Introduction
TFBS Bioscience Inc. was founded in 2016 as the first Contract Research Organization (CRO) providing biological testing in Taiwan. Our technical team's roots run deeper, going back to the virus research laboratory founded in 2009 at the Development Center of Biotechnology (DCB), a government-sponsored research institute in Taiwan. TFBS has established good reputation and track records in several regulatory submissions, winning trust from the international regulatory agencies and biopharmaceutical industry. TFBS has launched the first viral vectors Contract Development and Manufacturing Organization (CDMO) facility in Taiwan, providing fully integrated end-to-end contract development and manufacturing services for the needs of clinical trials. Nowadays, with our manufacturing expertise and state-of-the-art facility, we are determined to be the best partner offering clients a one-stop-shop solution for gene and cell therapy.
